Medical Education Grants
Jazz Pharmaceuticals (JAZZ) is committed to improving patient outcomes and providing support in compliance with local regulations.
Therapeutic Areas of Interest
- Educate on the screening, diagnosis and treatment of narcolepsy in adults and children,
including recognition of cataplexy
Educate on the burden of illness associated with Narcolepsy, including the pathophysiology
of narcolepsy, cardiovascular comorbidities, and cardiometabolic comorbidities
- Educate on the impact of treatment on long term functioning and QOL
- Educate on the MOA of narcolepsy treatments
- Educate on the impact of sodium content on health and the relevance of this risk to
- Educate on screening, diagnosis, and management of Idiopathic Hypersomnia and other
Excessive Daytime Sleepiness in Obstructive Sleep Apnea (EDS in OSA)
- Educate on EDS in OSA to include:
- Impact on Cognitive Function
- Quality of Life
Educate on new therapies to treat EDS in OSA and their impact on patient functioning and
Quality of Life.
Acute Myeloid Leukemia (AML)
- Educate on the role of intensive chemotherapy in the treatment of secondary AML
- Educate on identification and timely, actionable diagnosis of high risk AML subsets – AML-
- Educate on the treatment of secondary AML and other hematologic malignancies (e.g., MDS) to include:
- Impact on quality of life
- Educate on the appropriate management of secondary AML patients in the in-patient and
- Educate on the AML treatment paradigm (e.g., induction, consolidation, transplant)
- Educate on clinical and economic burden of secondary AML
- Educate on fitness assessment in secondary AML patients
Endothelial Related Complications
- Educate on risk factors, recognition, diagnosis, and early intervention of VOD/SOS
- Educate on VOD diagnostic criteria and severity grading in both adult and pediatric patients
- Educate on the pathophysiology and progressive nature of VOD and other post-transplant
complications associated with endothelial cell damage (i.e., GVHD, TA-TMA, IRI)
- Educate on the efficacy, safety and patient management of current and new therapies in the
treatment of VOD/SOS and other post-transplant complications associated with endothelial
- Educate on the clinical and economic burden of VOD/SOS and other post-transplant
complications associated with endothelial cell damage
Small Cell Lung Cancer (SCLC)
- Educate on treatment options in second-line therapy for small cell lung cancer
- Educate on current second-line therapies for SCLC to include:
- Patient Management
Acute Lymphoblastic Leukemia (ALL)
- Educate on the:
- Biology of immune response
- Management of asparaginase hypersensitivity reaction
- Impact on safety and efficacy
- Educate on the management of pediatric ALL with asparaginase (e.g., monitoring, PK,
safety, clinical value)
- Educate on asparaginase inspired protocols in AYA population
- Educate on the efficacy and clinical benefits of new asparaginase formulation in ALL
View our current requests for application.
Eligible educational grant applicants include the following (not an exhaustive list):
- Medical Schools
- Medical Associations/Medical Societies
- Hospitals/Medical Centers
- Medical Education Providers
This system is currently accepting requests for medical education meetings, conferences, or symposia; medical center grand rounds lectures; fellowships; enduring medical education activities; and similar educational activities.
In Europe & International (EU/INT) the system is also accepting requests for goods (such as books, printing, materials, equipment) and services (such as administrative support, personnel and tools).
The following grant requests are not covered by the educational grant request process: requests for funding educational activities that are promotional in nature (e.g., brand-specific promotional speaker activities); requests for funding activities related to promotion of a commercial product (e.g., commercial exhibits); and operational funding for patient advocacy organizations.
How to Apply
Grant requests to support US Medical Education and Medical and Education Goods and Services (MEGS) for EU/INT should be submitted using the Jazz Pharmaceuticals Request Management System.
The Jazz Pharmaceuticals (JAZZ) Grant Management System requires that all grant requests should be received by JAZZ in complete form at least 60 days prior to the commencement of the educational activity for consideration.
The system will guide applicants through the process of determining the request type and the required documents for each request.
Jazz Pharmaceuticals does not control or influence the content of programs or the selection of speakers, authors, or faculty planners.
All decisions regarding support are at the discretion of JAZZ and will be communicated by email.
Submission of a request does not guarantee support.
For more information, or for questions regarding the status of a grant request, please email firstname.lastname@example.org.